Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
01/2006
01/04/2006EP1546391A4 Energy transfer dyes, terminators and use thereof
01/04/2006EP1546125A4 Fluorescent labeling reagents with multiple donors and acceptors
01/04/2006EP1395585B1 Antibacterial agents
01/04/2006EP1383741A4 Process for the preparation of benazepril
01/04/2006EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes
01/04/2006EP1210714A4 High density non-volatile memory device
01/04/2006EP1150681B1 Use of a pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
01/04/2006EP1070083B1 Crystalline forms of 1s- [1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9- [[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino [1, 2-a][ 1,2] diazepine-1-carboxamide
01/04/2006CN1234709C Biporphin metal coordination compound with bridge linking face-face structure and its use
01/04/2006CN1234708C Novel imidazotriazinones and the use thereof
01/03/2006US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis
01/03/2006US6982265 Pyrrolotriazine inhibitors of kinases
01/03/2006US6982264 Enzyme inhibitors of beta-secretase-mediated cleavage of amyloid precuror proteins; congnition activators; Down's syndrome; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; Parkinson's disease; hemostatic agents
12/2005
12/29/2005WO2005123742A2 A new route to formyl-porphyrins
12/29/2005WO2005123741A1 Alkyl substituted indoloquinoxalines
12/29/2005WO2005123740A1 Use of 6-(2-tolyl)-triazolopyrimidines as fungicides, novel 6-(2-tolyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing the same
12/29/2005WO2005123739A1 6-(2-fluorophenyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing the same
12/29/2005WO2005123738A1 Pyrrazolo-pyrimidine derivatives
12/29/2005WO2005123737A2 Charge-transport materials, methods of fabrication thereof, and methods of use thereof
12/29/2005WO2005123256A1 Shaped body containing a microporous material and at least one silicon-containing binder, method for the production thereof and its use as a catalyst, particularly in a method for producing triethylenediamine (teda)
12/29/2005WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
12/29/2005WO2005123087A2 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
12/29/2005WO2005055939A3 Vinca derivatives
12/29/2005US20050288503 Novel compounds
12/29/2005US20050288502 Substituted heterocyclic compounds and methods of use
12/29/2005US20050288354 peroxisome proliferator activated receptor scaffold and modulator; 3-[1-(4-butoxy-benzenesulfonyl)-5-metoxy-1H-indol-3-yl]-propionic acid methyl etster; for identification or development of additional active compound; bioassay: binding affinity or specificity; antidiabetic, obesity, metabolic disorder
12/29/2005US20050288323 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine
12/29/2005US20050288313 Synergistically combined with immunomodulators or antiinflammtory agents; treating rheumatoid arthritis; inhibiting organ transplant rejection; Janus Kinase 3 inhibitors such as CP 690550, 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
12/29/2005US20050288312 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
12/29/2005US20050288296 2,3-Dimethylindolo[2,3-b]quinoxaline-6-yl-acetamide; 9-Chloro-2,3-dimethyl-6-(aminoethylamino-2-oxoethyl)-6H-indolo[2,3-b]quinoxaline; autoimmune diseases
12/29/2005US20050288295 Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
12/29/2005US20050288294 N-ethyl-N'-{(3R)-1-[4-(3-phenylthieno[3,4-b]pyrazin-2-yl)benzyl]pyrrolidin-3-yl}urea; inhibit activity of a serine, threonine protein kinase; cancer
12/29/2005US20050288293 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
12/29/2005US20050288290 e.g. 1-(4-(6-Chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-3-fluorophenyl)-3-(2-(4-fluorophenyl)acetyl)thiourea; mitogen-activated protein kinase inhibitor; anticarcinogenic agent, angiogenesis inhibitor; solid tumor, leukemia
12/29/2005US20050288289 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/29/2005US20050288275 New compounds
12/29/2005US20050287073 Carboranylporphyrins and uses thereof
12/29/2005CA2571487A1 Pyrrazolo-pyrimidine derivatives
12/29/2005CA2568799A1 Use of 6-(2-tolyl)-triazolopyrimidines as fungicides, novel 6-(2-tolyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing the same
12/29/2005CA2568379A1 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
12/28/2005EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
12/28/2005EP1608656A2 Imidazotriazine compounds
12/28/2005EP1608655A2 Pyrroloimidazole derivatives, their preparation, pharmaceutical compositions containing them, and their use as nootropic agents
12/28/2005EP1608654A2 8-SUBSTITUTED-6, 7, 8,9-TETRAHY9DROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES
12/28/2005EP1608653A1 SUBSTITUTED 8-PERFLUOROALKYL-6,7,8,9-TETRAHYDROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES
12/28/2005EP1608652A1 Pyrazolopyrimidine compounds and their use in medicine
12/28/2005EP1608651A1 Protein kinase inhibitors
12/28/2005EP1608650A1 Pyrene-linked pyrrolo(2,1-c)(1,4)benzodiazepine derivatives useful as anticancer agents
12/28/2005EP1608648A1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
12/28/2005EP1608632A1 Quinazolines useful as modulators of ion channels
12/28/2005EP1608631A2 Bi-cyclic pyrimidine inhibitors of tgf beta
12/28/2005EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
12/28/2005EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/28/2005EP1608364A1 Bicyclo-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/28/2005EP1608317A2 Dipeptidyl peptidase inhibitors
12/28/2005EP1389208B1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005CN1714091A Meso-substituted porphyrins
12/28/2005CN1714090A Quinolinyl-pyrrolopyrazoles
12/28/2005CN1714077A 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy.
12/28/2005CN1712404A Purification of porphyrin medicine
12/28/2005CN1712403A 2-phenyl substituted imidazotriazone compound for treating or preventing from impotence
12/28/2005CN1234026C Electric filter for electronic display
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979566 Method of treatment of viral infection including HIV using water soluble fullerenes—III
12/27/2005CA2354173C Novel process for the preparation of pyrazoles
12/27/2005CA2165819C Dc-89 derivatives
12/27/2005CA2153246C 5-alkoxy-1,2,4-triazolo[4,3-c]pyrimidine-3(2h)-thione compounds and their use in the preparation of 5-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine-2(3h)-thione and 3-hydrocarbylthio-5-alkoxy-1,2,4-triazolo[4,3-c]pyrimidine compounds
12/22/2005WO2005121147A1 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
12/22/2005WO2005121146A2 1, 2, 4-triazolo[1,5a]pyrimidines and use thereof for controlling plant-pathogenic fungi
12/22/2005WO2005121145A2 Octahydro-pyrrolo[3,4-c] derivatives and their use as antiviral compounds
12/22/2005WO2005121142A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido’2,3-d! pyrimidine derivatives and related compounds for the treatment of cancer
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121109A2 Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles
12/22/2005WO2005121107A1 Pyrazolo pyrimidines
12/22/2005WO2005121100A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/22/2005WO2005121094A1 Piperazine and piperidine derivatives as anti-hiv-agents
12/22/2005WO2005121073A1 Inhibitors of histone deacetylase
12/22/2005WO2005120573A2 Cationic bacteriochlorophyll derivatives and uses thereof
12/22/2005WO2005120516A2 Hiv integrase inhibitors
12/22/2005WO2005120233A1 Triazolopyrimidine compounds and use thereof for controlling harmful fungi
12/22/2005WO2005111031A3 Neuropeptide receptor modulators
12/22/2005WO2005097123A3 Pyridyl-substituted porphyrin compounds and methods of use thereof
12/22/2005WO2005095405A3 6-(2,6-dichlorophenyl)-triazolopyrimidines, methods for the production thereof, use thereof for controlling pathogenic fungi, and agents containing the same
12/22/2005WO2005080397A3 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
12/22/2005US20050283006 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282857 e.g. 1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-oxo-2-[4-(2-piperidin-1-yl-ethyl)-piperidin-1-yl]-ethyl 4-(2-oxo-1 ,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; migraine or cluster headaches, non-insulin-dependent diabetes
12/22/2005US20050282847 Oxidizing a 4-substituted-2-thiopyrimidine and reacting the sulfone formed with an alkylcyanamide; both thio and sulfonyl intermediates of 4-substitutedaminopyridines are claimed, e.g., 4,6-dichloro-5-(2-chloro-6-fluorophenyl)-2-methylthiopyrimidine
12/22/2005US20050282844 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/22/2005US20050282828 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
12/22/2005US20050282827 Pyrazolo-pyrimidine derivatives
12/22/2005US20050282826 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of beta-secretase
12/22/2005US20050282814 Vasculostatic agents and methods of use thereof
12/22/2005US20050282813 imidazo(1,5-a)-pyrazine-1,3-dione derivatives; Anticancer agents; immune disorders; (5S,8S,8aR)-4-[Octahydro-7-[(1,1-dimethylethoxy)carbonyl]-1,3-dioxo-5,8-methanoimidazo[1,5-a]pyrazin-2-yl]-2-(trifluoromethyl)benzonitrile
12/22/2005US20050282811 Diazabicyclic histamine-3 receptor antagonists
12/22/2005US20050282810 Oxindole derivatives
1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 573